Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Other Current Payables: ¥239 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600488 Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
63 GF Score
Price ¥5.06
GF Value ¥3.59
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Tianjin Tianyao Pharmaceutical Co Other Current Payables?

Tianjin Tianyao Pharmaceutical Co SHSE:600488 -3.25% 63 Other Current Payables is ¥239 Mil as of Mar. 2026. GuruFocus rates SHSE:600488 with a GF Score™ of 63/100 and a GF Value™ of ¥3.59 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Tianjin Tianyao Pharmaceutical Co's Other Current Payables for the quarter that ended in Mar. 2026 was ¥239 Mil.

Tianjin Tianyao Pharmaceutical Co's quarterly Other Current Payables declined from Sep. 2025 (¥296 Mil) to Dec. 2025 (¥275 Mil) and declined from Dec. 2025 (¥275 Mil) to Mar. 2026 (¥239 Mil).

Tianjin Tianyao Pharmaceutical Co's annual Other Current Payables increased from Dec. 2023 (¥349 Mil) to Dec. 2024 (¥353 Mil) but then declined from Dec. 2024 (¥353 Mil) to Dec. 2025 (¥275 Mil).

Tianjin Tianyao Pharmaceutical Co Other Current Payables Related Terms

Tianjin Tianyao Pharmaceutical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Tianjin Tianyao Pharmaceutical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin Tianyao Pharmaceutical Co Other Current Payables Chart

Tianjin Tianyao Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 286.86 361.49 348.91 353.04 275.20

Tianjin Tianyao Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 281.32 302.61 295.83 275.20 238.63
SHSE:600488
63GF Score
Tianjin Tianyao Pharmaceutical Co Ltd SHSE:600488
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin Tianyao Pharmaceutical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥239 Mil mean?
Tianjin Tianyao Pharmaceutical Co (SHSE:600488) has a Other Current Payables of ¥239 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors.
Is Tianjin Tianyao Pharmaceutical Co's Other Current Payables too high?
Tianjin Tianyao Pharmaceutical Co's current Other Current Payables is ¥239 Mil. Overall, Tianjin Tianyao Pharmaceutical Co has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Tianyao Pharmaceutical Co's Other Current Payables compare to ZTS and UTHR?
Tianjin Tianyao Pharmaceutical Co's Other Current Payables of ¥239 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Tianjin Tianyao Pharmaceutical Co and its competitors. Tianjin Tianyao Pharmaceutical Co's current Other Current Payables is ¥239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Tianyao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co (SHSE:600488) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.59, compared to a current price of ¥5.06 — trading 40.9% above its estimated fair value. The current Other Current Payables is ¥239 Mil. Tianjin Tianyao Pharmaceutical Co's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Tianjin Tianyao Pharmaceutical Co (SHSE:600488), the current Other Current Payables is ¥239 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin Tianyao Pharmaceutical Co (SHSE:600488) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin Tianyao Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥5.06 is trading 40.9% above its estimated GF Value™ of ¥3.59. GuruFocus considers Tianjin Tianyao Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:600488:

  • Other Current Payables: ¥239 Mil
  • GF Value™: ¥3.59 vs. price of ¥5.06 (40.9% above fair value)
  • GF Score™: 63/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tianjin Tianyao Pharmaceutical Co Business Description

Address No. 221 Huanghai Road, Tianjin Development Zone, Tianjin, CHN, 300457
Tianjin Tianyao Pharmaceutical Co Ltd is a China-based company engages in the development, manufacture, distribution, and export of pharmaceutical products. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate.
63GF Score

Get the complete analysis for SHSE:600488

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.06
Price
¥3.59
GF Value